Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,290 | -245,874 | -174,587 | -109,680 | -52,757 |
| Depreciation Amortization | 1,710 | 8,266 | 6,497 | 4,451 | 2,372 |
| Accounts payable and accrued liabilities | 2,989 | 2,502 | 3,842 | 2,825 | 2,638 |
| Other Working Capital | -8,476 | 26,302 | 19,324 | -398 | -4,727 |
| Other Operating Activity | 10,862 | 47,829 | 31,629 | 18,252 | 7,579 |
| Operating Cash Flow | $-61,205 | $-160,975 | $-113,295 | $-84,550 | $-44,895 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,135 | 101,305 | 108,994 | 53,825 | 24,795 |
| PPE Investments | -485 | -10,188 | -9,522 | -6,521 | -1,477 |
| Other Investing Activity | 0 | 0 | -1,202 | -1,543 | -1,543 |
| Investing Cash Flow | $-10,620 | $91,117 | $98,270 | $45,761 | $21,775 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 68,969 | 138,676 | 63,736 | 289 | 314 |
| Financing Cash Flow | $68,969 | $138,676 | $63,736 | $289 | $314 |
| Exchange Rate Effect | 17 | -65 | 0 | N/A | N/A |
| Beginning Cash Position | 164,607 | 95,854 | 93,569 | 93,569 | 93,569 |
| End Cash Position | 161,768 | 164,607 | 142,280 | 55,069 | 70,763 |
| Net Cash Flow | $-2,839 | $68,753 | $48,711 | $-38,500 | $-22,806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,205 | -160,975 | -113,295 | -84,550 | -44,895 |
| Capital Expenditure | -485 | -10,188 | -9,522 | -6,521 | -1,477 |
| Free Cash Flow | -61,690 | -171,163 | -122,817 | -91,071 | -46,372 |